LEADER 05530nam 2200349Ia 4500 |
008 090917s2008 us m b y001 0 eng |
020 ^a1573317047 |
020 ^a9781573317047 |
040 ^acl |
060 04 ^aW1^bAn613 v.1144 2008 |
245 00 ^aNeural signaling :^bopportunities for novel diagnostic approaches and therapies /^ceditor, Edward J. Goetzl. |
260 ^aBoston, Mass. :^bPublished by Blackwell Pub. on behalf of the New York Academy of Sciences,^cc2008. |
300 ^axiii, 265 p. :^bill. ;^c26 cm. |
440 0 ^aAnnals of the New York Academy of Sciences,^x0077-8923 ;^vv.1144. |
500 ^a"This vlume in the result of a symposium, entitled International Conference on Neural Signalings Opportunities for Novel Diagnostic Approaches and Therapies, held at Asilomar Conference Grounds in Pacific Grove, California on February 16-20, 2008."--P. v. |
504 ^aIncludes bibliographical references and index. |
505 0 ^aPt. I. New biology of cellular receptors for neuromediators: regulation of expression, signal transduction, and mechanisms fo cross-talk. -- G protein-coupled receptor structures, molecular associations, and modes of regulation / Laurence J. Miller -- Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo / Lee E. Eiden ... [et al.] -- Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decasy of time-resolved fluorescence anisotropy / Kaleeckal G. Harikumar, Laurence J. Miller -- Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system / Bo Ahrโen -- Parathyroid hormone-related protein regulates glioma-associated oncogene transcriptional activation: lessons learned from bone development and cartilage neoplasia / Benjamin A. Alman, Jay S. Wunder -- Molecular mechanisms of TRPV4-mediated neural signaling / Wolfgang Liedtke -- Sall2 transcription factor is a novel p75NTR binding protein that promotes the development and function of neurons / Roxana Pincheira, David B. Donner -- Pt. II. Neuromediator participation in host defense, immunity, and inflammation. -- Diverse mechanisms and consequences of immunoadoption of neuromediator systems / Edward J. Goetzl, Robert C. Chan, Mahesh Yadav -- Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry / Karl Ebner ... [et al.] -- Human mast cells stimulate activated T cells: implications for multiple sclerosis / Theoharis C. Theoharides ... [et al.] -- Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity / Mahesh Vadav, Edward J. Goetzl -- Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis / Steven D. Douglas ... [et al.] -- Pt. III. Neuromediators in diseases. -- Glutamate and neurotrophic factors in neuronal plasticity and disease / Mark P. Mattson -- Diversity of neuropathogenic mechanisms and implications for neuromediation of diseases / Susan E. Leeman -- Inhibitory effects of a neurokinin-1 receptor antagonist on postoperative peritoneal adhesion formation / Karen L. Reed ... [et al.] -- Neuropeptides, mesenteric fat, and intestinal inflammation / Iordanes Karagiannides , Charalabos Pothoulakis -- Gastrin-releasing peptide, immune responses, and lung disease / Simone Degan ... [et al.] -- Vasoactive intestinal peptide gene is a key modulator of pulmonary vascular remodeling and inflammation / Sami I. Said -- Pt. IV. Neuromediators in prenatal development and stress. -- Prenatal aalcohol exposure increases vulnerable to stress and anxiety-like disorders in adulthood / Kim G.C. Hellemans ... [et al.] -- Role of various neurotransmitters in mediating the long-term endocrine consequences of prenatal alcohol exposure / Soon Lee ... [et al.] -- Perinatal maternal fat intake affects metabolism and hippocampal function in the offspring: a potential role for leptin / Claire-Dominique Walker ... [et al.] -- Pt. V. Diagnostic and therapeutic strategies for neuromediators in diseases. -- Informed development of drugs acting at family B G protein-coupled receptors / Laurence J. Miller -- Experimental therapeutic strategies for severe sepsis: mediators and mechanisms / William R. Parrish ... [et al.] -- Activation of the proopiomelanocortin gene with ketoconazole as a tratment for Parkinson's disease: a new hypothesis / Alberto Halabe Bucay -- Opportunities and challenges in the discovery of new central nervous system drugs / James E. Krause, Bertrand L. Chenard -- Molecular imaging to biomarker development in neuroscience / J. James Frost -- Studying the brian-gut axis with pharmacological imaging / Kristen Tillisch ... [et al.] |
650 2 ^aSynaptic Transmission^xphysiology. |
650 2 ^aSignal Transduction^xphysiology. |
650 2 ^aReceptors, Neuropeptide. |
650 2 ^aNeuropeptides. |
650 2 ^aReceptors, Neurotransmitter. |
650 2 ^aNeurotransmitter Agents. |
650 0 ^aNeuropharmacology. |
650 0 ^aSecond messengers (Biochemistry) |
650 0 ^aNeurotransmitters. |
650 0 ^aNeuropeptides. |
700 1 ^aGoetzl, Edward J.,^eed. |
710 2 ^aNew York Academy of Sciences. |
711 2 ^aInternational Conference on Neural Signalings Opportunities for Novel Diagnostic Approaches and Therapies ^d(2008 :^cCalifornia) |
913 ^a- |
995 ^aRatchanee Kittirangsee |